4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-23-030185
Chief Commercial Officer gave up 2,482 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Gayer Charles K · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-19 | Shares withheld for taxes : show line 1 in the form | −2,482 | $6.05 | $15,016 | 274,533 | D |
Loading xslF345X05/form4.xml…